Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study

ImmunoTargets and Therapy · Published 2026-07-01 · DOI 10.2147/itt.s616114

Free full text

Authors (5)

Yingying Yang, Nan Kang, Ying Zhu, Chi Ma, Ruixia Zhu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yang, Y., Kang, N., Zhu, Y., et al. (2026). Targeting BLyS and APRIL with Telitacicept versus Conventional Immunotherapy in Generalized Myasthenia Gravis: A Comparative Study. ImmunoTargets and Therapy. https://doi.org/10.2147/itt.s616114

Related articles